PLASMA EXPANDER MARKET ANALYSIS

Name: Plasma Expander Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy

Plasma Expander Market, By Type (Albumin, Dextran, Hydroxyethyl Starch, Gelatin, and Others), By Product Type (Colloids and Synthetic Expanders), By Application (Trauma and Surgical Procedures, Burn Management, Hypovolemia, Sports Medicine, and Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Recent Developments

In January 2022, Fresenius Kabi AG a pharmaceutical company expanded plasma expander manufacturing facility in Germany. The expansion increased the plant's production capacity by 30%. This allows Fresenius Kabi to better cater to the growing demand for plasma expanders and intravenous solutions in Europe and global markets.
In March 2021, Grifols, S.A. a pharmaceutical company acquired 25 U.S.-based plasma donation centers from BPL Plasma Inc., a subsidiary of Bio Products Laboratory Holdings Limited. Grifols will immediately increase its plasma supply following the acquisition of these 25 plasma centers, which obtain a run-rate of 1 Mn liters of plasma per year.
In July 2020, Grifols acquired GC Pharma’s plasma fractionation facility for US$460 Mn. The deal also covers two purification facilities, as well as 11 U.S.-based plasma collection centres. This acquisition expands plasma collection and fractionation capacity to enable access to plasma-derived medicines worldwide.